002107.SZ · 沃华医药
China A-shares · RS rating 83 · As of 2026-10-14
| Price | 6.69 CNY |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 67 / 67 / 76 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 34 / 42 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -20.4% |
| Distance from 52-week high | +17.5% |
| Market cap (USD) | $634.5M |